Treatment of cancer during pregnancy with monoclonal antibodies: a real challenge.
Azim
Hatem A
HA
Azim
Hamdy
H
Peccatori
Fedro A
FA
D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D058846:Antibodies, Monoclonal, Murine-Derived / Q000627:therapeutic use*; D000951:Antigens, Neoplasm / Q000276:immunology; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects / Q000627:therapeutic use*; D000075202:Contraindications; D005260:Female; D047109:Fetal Development / Q000187:drug effects; D006801:Humans; D021041:Placental Circulation; D011247:Pregnancy; D011252:Pregnancy Complications, Neoplastic / Q000188:drug therapy* / Q000276:immunology; D000069283:Rituximab; D018675:Toxicity Tests / Q000639:trends; D000068878:Trastuzumab
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D058846:Antibodies, Monoclonal, Murine-Derived; D000951:Antigens, Neoplasm; D000069283:Rituximab; D000068878:Trastuzumab